Please be advised that AstraZeneca has transferred all rights for LUMOXITI® (moxetumomab pasudotox-tdfk) to Innate Pharma S.A. as of April 1, 2020. For questions or assistance, please call InnateCares, Monday through Friday, 8 am – 8 pm Eastern Time at 1-844-694-6628.
Helps you identify and understand prescription coverage, out-of-pocket costs, and pharmacy options
Helps you understand prior authorization requirements for insurance and obtain a response for submitted requests
Helps you identify your patient’s pharmacy options and helps with the prescription process
Assists with pharmacy coordination, whether distribution is through a Specialty Pharmacy Provider, Specialty Distributor and in-office dispensing, retail pharmacy, home health, or any combination of these
Helps your patients access AstraZeneca medicines in a timely manner. Access 360 can follow up on submissions to an insurance company or a pharmacy
Reviews a denial, helps you understand insurance appeal requirements, and obtains a response for submitted requests
Identifies the best available option to help qualified patients access and afford their medications
